Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2018
At a glance
- Drugs Ulipristal (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Acronyms ellipse II
- Sponsors HRA Pharma
- 30 Jul 2018 Status changed from recruiting to completed.
- 06 Jun 2017 Planned End Date changed from 1 Apr 2015 to 1 Dec 2017.
- 06 Jun 2017 Planned primary completion date changed from 1 Mar 2014 to 1 Dec 2017.